{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:16:12Z","timestamp":1791288972207,"version":"4.3.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1136\/ard.55.12.888","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"888-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane."],"prefix":"10.1016","volume":"55","author":[{"given":"Y.T","family":"Konttinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ceponis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vuorikoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kortekangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sorsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sukura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Santavirta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"917","article-title":"The complement system","volume-title":"immunology","author":"Liszewski, M.K.; Atkinson, J.P.","year":"1993","unstructured":"Liszewski MK, Atkinson JP. The complement system. In: Paul W E, ed. Fundamental immunology, 3rd ed. New York: Raven Press, 1993:917-39.","edition":"3rd ed"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/art.1780290603","article-title":"Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex","volume":"29","year":"1986","unstructured":"Mollnes TE, Lea T, Mellbye OJ, Pahle J, Grand 0, Harboe M. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. Arthritis Rheum 1986;29:715-21.","journal-title":"Arthritis Rheum"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.47.3.190","article-title":"Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy","volume":"47","author":"Doherty, M.; Richards, N.; Hornby, J.; Powell, R.","year":"1988","unstructured":"Doherty M, Richards N, Hornby J, Powell R Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis 1988;47:190-7.","journal-title":"Ann Rheum Dis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/03009749109103019","article-title":"C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis","volume":"20","author":"Olmez, U.; Garred, P.; Mollnes, T.E.; Harboe, M.; Berntzen, H.B.; Munthe, E.","year":"1991","unstructured":"Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis. ScandJ Rheumatol 1991;20:183-9.","journal-title":"ScandJ Rheumatol"},{"key":"ref_5","first-page":"82","article-title":"Complement C3 cleavage product in synovial fluids detected by immunofixation","volume":"50","author":"Partsch, G.; Bauer, K.; Br6ll, H.; Petera, P.; Dunky, A.; Meretey, K.","year":"1991","unstructured":"Partsch G, Bauer K, Br6ll H, Petera P, Dunky A, Meretey K. Complement C3 cleavage product in synovial fluids detected by immunofixation. Z Rheumatol 1991;50:82-5.","journal-title":"Z Rheumatol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.1780341209","article-title":"Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis","volume":"34","author":"Brodeur, J.P.; Ruddy, S.; Schwartz, L.B.; Moxley, G.","year":"1991","unstructured":"Brodeur JP, Ruddy S, Schwartz LB, Moxley G. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1531-7.","journal-title":"Arthritis Rheum"},{"key":"ref_7","first-page":"1028","article-title":"Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy","volume":"13","author":"Sanders, M.E.; Kopicky, J.A.; Wigley, F.M.; Shin, M.I.; Frank, M.M.; Joiner, K.A.","year":"1986","unstructured":"Sanders ME, Kopicky JA, Wigley FM, Shin MI, Frank MM, Joiner KA. Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy. J Rheumatol 1986; 13:1028-34.","journal-title":"J Rheumatol"},{"key":"ref_8","first-page":"14762","article-title":"Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies","volume":"37","author":"Kemp, P.A.; Spragg, J.H.; Brown, J.C.; Morgan, B.P.; Gunn, C.A.; Taylor, P.W.","year":"1992","unstructured":"Kemp PA, Spragg JH, Brown JC, Morgan BP, Gunn CA, Taylor PW. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. J Clin Lab Immunol 1992;37:14762.","journal-title":"J Clin Lab Immunol"},{"key":"ref_9","first-page":"433","article-title":"Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Clin Exp Rheumatol","volume":"10","author":"Corvetta, A.; Pomponio, G.; Rinaldi, N.; Luchetti, M.M.; Di Loreto, C.; Stramazzoti, D.","year":"1992","unstructured":"Corvetta A, Pomponio G, Rinaldi N, Luchetti MM, Di Loreto C, Stramazzoti D. Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Clin Exp Rheumatol 1992;10:433-8."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198608213150805","article-title":"The role of complement and its receptor in the elimination of immune complexes","volume":"315","author":"Schifferli, J.A.; Ng, Y.C.; Peters, D.K.","year":"1986","unstructured":"Schifferli JA, Ng YC, Peters DK. The role of complement and its receptor in the elimination of immune complexes. NEnglJVMed 1986;315:488-95.","journal-title":"NEnglJVMed"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.49.10.747","article-title":"Measurement of the chemotactic complement fragments C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase","volume":"49","author":"Jose, P.J.; Moss, I.K.; Maini, R.N.; Williams, T.J.","year":"1990","unstructured":"Jose PJ, Moss IK, Maini RN, Williams TJ. Measurement of the chemotactic complement fragments C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis 1990; 49:747-52.","journal-title":"Ann Rheum Dis"},{"key":"ref_12","first-page":"467","article-title":"In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. Clin Exp Immunol","volume":"73","author":"Morgan, B.P.; Daniels, R.H.; Watts, M.J.; Williams, B.D.","year":"1988","unstructured":"Morgan BP, Daniels RH, Watts MJ, Williams BD. In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. Clin Exp Immunol 1988;73:467-72."},{"key":"ref_13","first-page":"237","article-title":"Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack","volume":"69","author":"Daniels, R.H.; Houston, W.A.J.; Petersen, M.M.; Williams, J.D.; Williams, B.D.; Morgan, B.P.","year":"1990","unstructured":"Daniels RH, Houston WAJ, Petersen MM, Williams JD, Williams BD, Morgan BP. Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack. Immunology 1990;69:237-42.","journal-title":"Immunology"},{"key":"ref_14","first-page":"329","article-title":"Interaction of the terminal complement components C5b-9 with synovial fibroblasts-binding to themembrane surface leads to increased levels in collagenase-specific messenger RNA","volume":"78","author":"Jahn, B.; von Kempis, J.; Kramer, K.L.; Filsinger, S.; Hansch, G.M.","year":"1993","unstructured":"Jahn B, von Kempis J, Kramer KL, Filsinger S, Hansch GM. Interaction of the terminal complement components C5b-9 with synovial fibroblasts-binding to themembrane surface leads to increased levels in collagenase-specific messenger RNA. Immunology 1993;78:329-34.","journal-title":"Immunology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface","volume":"264","author":"Hattori, R.; Hamilton, K.K.; McEver, R.P.; Sims, P.J.","year":"1989","unstructured":"Hattori R, Hamilton KK, McEver RP, Sims PJ. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989;264:9053-60.","journal-title":"J Biol Chem"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.170.3.637","article-title":"CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells","volume":"170","author":"Davies, A.; Simmons, D.I.; Hale, G.; Harrison, R.A.; Tighe, H.; Lachman, P.J.","year":"1989","unstructured":"Davies A, Simmons DI, Hale G, Harrison RA, Tighe H, Lachman PJ, et al. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 1989;170:637-54.","journal-title":"J Exp Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199309303291407","article-title":"Acute monoarthritis","volume":"329","author":"Baker, D.G.; Shumacher, H.R.","year":"1993","unstructured":"Baker DG, Shumacher HR. Acute monoarthritis. N Engl J Med 1993;329: 1013-20.","journal-title":"N Engl J Med"},{"key":"ref_18","first-page":"315","article-title":"et aL","volume":"31","author":"Arnett, F.C.; Edworthy, S.M.; Bloch, D.A.; McShane, D.J.; Fries, J.F.; Cooper, N.S.","year":"1987","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et aL The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.","journal-title":"The American Rheumatism Association; revised criteria for the classification of rheumatoid arthritis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoartbritis. Classification of osteoarthritis of the knee","volume":"29","author":"Altman, R.; Asch, E.; Bloch, D.; Bole, G.; Borenstein, D.; Brandt, K.","year":"1986","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoartbritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.","journal-title":"Arthritis Rheum"},{"key":"ref_20","first-page":"316","article-title":"Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease","volume":"23","author":"Davies, M.E.; Homer, A.; Loveland, B.E.; McKenzie, I.F.C.","year":"1994","unstructured":"Davies ME, Homer A, Loveland BE, McKenzie IFC. Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease. ScandJ7 Rheumatol 1994;23:316-21."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/rheumatology\/25.3.266","article-title":"The ninth complement component in rheumatoid arthritis, Behcet's disease and other rheumatic diseases","volume":"25","author":"Rumfeld, W.R.; Morgan, B.P.; Campbell, A.K.","year":"1986","unstructured":"Rumfeld WR, Morgan BP, Campbell AK. The ninth complement component in rheumatoid arthritis, Behcet's disease and other rheumatic diseases. Br Jf Rheumatol 1986;25:266-70.","journal-title":"Br Jf Rheumatol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00301260","article-title":"Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium","volume":"13","author":"Guc, D.; Gulati, P.; Lemercier, C.; Lappin, D.; Birnie, G.D.; Whaley, K.","year":"1993","unstructured":"Guc D, Gulati P, Lemercier C, Lappin D, Birnie GD, Whaley K. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium. Rheumatol Int 1993;13:139-46.","journal-title":"Rheumatol Int"},{"key":"ref_23","first-page":"65","article-title":"Regulation of complement membrane attack complex formation in myocardial infarction","volume":"143","author":"Vdkeva, A.; Laurila, P.; Meri, S.","year":"1993","unstructured":"Vdkeva A, Laurila P, Meri S. Regulation of complement membrane attack complex formation in myocardial infarction. Am J Pathol 1993;143:65-75.","journal-title":"Am J Pathol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.4049\/jimmunol.130.4.1891","article-title":"Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase","volume":"130","author":"Schwartz, L.B.; Kawahara, M.S.; Hugli, T.E.; Vik, D.; Fearon, D.T.; Austen, K.F.","year":"1983","unstructured":"Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 1983; 130:1891-5.","journal-title":"J Immunol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000463070","article-title":"The pathobiology of the terminal complement complexes","volume":"6","author":"Dalmasso, A.P.; Falk, R.J.; Raij, L.","year":"1989","unstructured":"Dalmasso AP, Falk RJ, Raij L. The pathobiology of the terminal complement complexes. Complement Inflamm 1989; 6:36-48.","journal-title":"Complement Inflamm"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0161-5890(93)90009-Z","article-title":"Associated complement C3b. Towards an understanding of its intracellular modifications","volume":"30","author":"Rey-Millet, C.A.; Chesne, S.; Colomb, M.G.","year":"1993","unstructured":"Rey-Millet CA, Chesne S, Colomb MG. Associated complement C3b. Towards an understanding of its intracellular modifications. Mol Immunol 1993;30:855-64.","journal-title":"Mol Immunol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/ard.54.5.408","article-title":"Synovial hyaluronate in rheumatoid arthritis binds Clq and is covalently bound to antibodies: a model for chronicity","volume":"54","author":"Prehm, P.","year":"1995","unstructured":"Prehm P. Synovial hyaluronate in rheumatoid arthritis binds Clq and is covalently bound to antibodies: a model for chronicity. Ann Rheum Dis 1995;54:408-12.","journal-title":"Ann Rheum Dis"},{"key":"ref_28","first-page":"532","article-title":"Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues","volume":"65","author":"Meri, S.; Waldmann, H.; Lachman, P.J.","year":"1991","unstructured":"Meri S, Waldmann H, Lachman PJ. Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 1991;65:532-7.","journal-title":"Lab Invest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0039.1992.tb02048.x","article-title":"The CD59 antigen-a multifunctional molecule","volume":"40","author":"Walsh, L.A.; Tone, M.; Thiru, S.; Waldmann, H.","year":"1992","unstructured":"Walsh LA, Tone M, Thiru S, Waldmann H. The CD59 antigen-a multifunctional molecule. Tissue Antigens 1992;40:213-20.","journal-title":"Tissue Antigens"},{"key":"ref_30","first-page":"608","article-title":"Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction","volume":"67","author":"Vakeva, A.; Laurila, P.; Meri, S.","year":"1992","unstructured":"Vakeva A, Laurila P, Meri S. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab Invest 1992;67:608-16.","journal-title":"Lab Invest"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1182\/blood.V75.1.284.284","article-title":"Erythrocyte membrane inhibitor of reactive lysis: effects ofphosphatidylinositol-specific phospholipase C on the isolated and cell associated protein","volume":"75","author":"Holguin, M.H.; Wilcox, L.A.; Bernshaw, N.J.; Rosse, W.F.; Parker, C.J.","year":"1990","unstructured":"Holguin MH, Wilcox LA, Bernshaw NJ, Rosse WF, Parker CJ. Erythrocyte membrane inhibitor of reactive lysis: effects ofphosphatidylinositol-specific phospholipase C on the isolated and cell associated protein. Blood 1990; 75:284-9.","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.1995.11","article-title":"Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells","volume":"73","author":"Yuan, F.F.; Bryant, J.A.; Fletcher, A.","year":"1995","unstructured":"Yuan FF, Bryant JA, Fletcher A. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells. Immunol Cell Biol 1995;73:66-72.","journal-title":"Immunol Cell Biol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1016\/S0021-9258(18)42266-1","article-title":"The human complement regulatory protein CD59 binds to the a-chain of C8 and to the \"b\" domain of C9","volume":"267","author":"Ninomiya, H.; Sims, P.J.","year":"1992","unstructured":"Ninomiya H, Sims PJ. The human complement regulatory protein CD59 binds to the a-chain of C8 and to the \"b\" domain of C9.J Biol Chem 1992;267:13675-80.","journal-title":"J Biol Chem"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0021-9150(92)90060-T","article-title":"CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions","volume":"96","author":"Seifert, P.S.; Roth, I.; Schmiedt, W.; Oelert, H.; Okada, N.; Okada, H.","year":"1992","unstructured":"Seifert PS, Roth I, Schmiedt W, Oelert H, Okada N, Okada H, et al. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions. Atherosclerosis 1992;96:135-45.","journal-title":"Atherosclerosis"},{"key":"ref_35","first-page":"820","article-title":"Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells","volume":"71","author":"Hakulinen, J.; Meri, S.","year":"1994","unstructured":"Hakulinen J, Meri S. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Lab Invest 1994;71:820-7.","journal-title":"Lab Invest"},{"key":"ref_36","first-page":"830","article-title":"Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage","volume":"70","author":"Venneker, G.T.; van den Hoogen, F.H.; Boerbooms, A.M.; Bos, J.D.; Asghar, S.S.","year":"1994","unstructured":"Venneker GT, van den Hoogen FH, Boerbooms AM, Bos JD, Asghar SS. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage. Lab Invest 1994;70:830-5.","journal-title":"Lab Invest"},{"key":"ref_37","first-page":"18997","article-title":"Glycosylphosphatidylinositol (GPI)-anchored membrane proteins are constitutively down-regulated in psoriatic skin","volume":"172","author":"Venneker, G.T.; Das, P.K.; Meinardi, M.M.; van Marle, J.; van Veen, H.A.; Bos, J.D.","year":"1994","unstructured":"Venneker GT, Das PK, Meinardi MM, van Marle J, van Veen HA, Bos JD, et al. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins are constitutively down-regulated in psoriatic skin. J Pathol 1994;172: 18997.","journal-title":"J Pathol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724001663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724001663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.55.12.888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:22:29Z","timestamp":1738304549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724001663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S0003496724001663"],"URL":"https:\/\/doi.org\/10.1136\/ard.55.12.888","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1996,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.55.12.888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}